Energy consumption characterization in precision hard machining using CBN cutting tools

In this paper, the contribution of tool wear to the energy balance was determined for precision hard turning using chamfered CBN cutting tools. The tool nose wear VBC and the corresponding changes of component forces Fc, Ff and Fp resulting from tool wear evolution were continuously measured during wear tests. Based on the cutting mechanics, specific cutting and ploughing energies were calculated for a number of tool wear states. In particular, changes of energy balance due to tool wear under variable feed rate, depth of cut and tool nose radius were discussed. A distinction between material removal conditions resulting from precision cutting and grinding at a very low uncut chip thickness is considered. © 2015, The Author(s)

Correlation Between Friction and Wear of Cubic Borone Nitride Cutting Tools in Precision Hard Machining

In this paper, the contribution of tool wear to friction was determined for precision hard turning using Cubic Borone Nitride (CBN) cutting tools. The tool nose wear VB C and the corresponding changes of component forces F c , F f , and F p resulting from tool wear evolution were continuously measured during wear tests. Based on the mechanics of nonorthogonal cutting, the normal and friction forces acting on rake and flank faces were calculated for all measuring points, and as a result, relevant changes of the friction coefficient were determined. Additionally, friction changes resulting from tool wear under different feed rate, depth of cut, and tool nose radius were discussed in terms of the plowing energy produced by the tool nose

Fully Modular Robotic Arm Architecture Utilizing Novel Multifunctional Space Interface

The current paradigm in space robotics is the design of specialized robotic manipulators to meet the requirements for a specific mission profile. This research aims to develop a novel concept of a modular robotic arm for multi-purpose and multi-mission use. The overall approach is based on a manipulator formed by serial connection of identical modules. Each module contains one rotational joint. The joints, rotation axis is tilted under an angle of 45° to the normal axis, which requires less stowage space compared to a traditional joint configuration. A manipulator can be reconfigured in orbit by adding or removing modules and end effectors, therefore modifying the degrees of freedom (DoF) as well as the workspace. Redundancies are introduced, since defect modules may be removed or replaced. This paper outlines the overall concept of modularization of a robotic arm. The development and mechanical design of a terrestrial demonstrator based on the multifunctional interface iSSI (intelligent Space System Interface) is presented, which is intended for OOS and OOA activities. Furthermore, a variant of the modular robotic system with 24 DoF is presented, which can be stowed in a Cubesat-sized environment. It can operate in spaces with limited accessibility and is dedicated for tasks like inspection and delicate repairs. Finally, an outlook to further research potential and future use cases for the modular robotic system is given.BMWi, 50RP1960A, Verbundvorhaben HOMER: Hoch-redundante modulare Robotersysteme zum flexiblen Einsatz in der Raumfahrt und der Automotive-Serienfertigung; Teilvorhaben Kinematik und RedundanzBMWi, 50RP1960B, Verbundvorhaben: HOMER - Hoch-redundante modulare Robotersysteme zum flexiblen Einsatz in der Raumfahrt und der Automotive-Serienfertigung; Teilvorhaben: modulare Robotikstrukture

Automatisierte Interpretation und Ergebnis-Bereitstellung von Daten einer digitalisierten Meteor-Beobachtungsstation

Diese Arbeit befasst sich mit der automatischen Datenanalyse einer digitalen Meteor-Beobachtungsstation. Hierzu wurden Analysen über mögliche Prozeduren und zurzeit vorhandene Methoden zur automatischen Meteorerkennung angestellt. Es wurde die Umsetzbarkeit für den routinemäßigen Betrieb mit der digitalen Version der Europäischen Feuerkugelnetzwerk Beobachtungsstationen untersucht. Dazu wurde mit grundlegendem Wissen der digitalen Bildverarbeitung eine für die Meteorbeobachtung mit digitaler Kameratechnik nutzbare automatische Meteor-Erkennungssoftware Canon Eos Meteor Detection (CEOS MetDetect) entwickelt und deren Funktion geprüft

InnoCube — a wireless satellite platform to demonstrate innovative technologies

A new innovative satellite mission, the Innovative CubeSat for Education (InnoCube), is addressed. The goal of the mission is to demonstrate “the wireless satellite”, which replaces the data harness by robust, high-speed, real-time, very short-range radio communications using the SKITH (SKIpTheHarness) technology. This will make InnoCube the first wireless satellite in history. Another technology demonstration is an experimental energy-storing satellite structure that was developed in the previous Wall#E project and might replace conventional battery technology in the future. As a further payload, the hardware for the concept of a software-based solution for receiving signals from Global Navigation Satellite Systems (GNSS) will be developed to enable precise position determination of the CubeSat. Aside from technical goals this work aims to be of use in the teaching of engineering skills and practical sustainable education of students, important technical and scientific publications, and the increase of university skills. This article gives an overview of the overall design of the InnoCube

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Background: Patent foramen ovale (PFO) is a contributor to embolic stroke of undetermined source (ESUS). Subgroup analyses from previous studies suggest that anticoagulation could reduce recurrent stroke compared with antiplatelet therapy. We hypothesised that anticoagulant treatment with rivaroxaban, an oral factor Xa inhibitor, would reduce the risk of recurrent ischaemic stroke compared with aspirin among patients with PFO enrolled in the NAVIGATE ESUS trial. Methods: NAVIGATE ESUS was a double-blinded, randomised, phase 3 trial done at 459 centres in 31 countries that assessed the efficacy and safety of rivaroxaban versus aspirin for secondary stroke prevention in patients with ESUS. For this prespecified subgroup analysis, cohorts with and without PFO were defined on the basis of transthoracic echocardiography (TTE) and transoesophageal echocardiography (TOE). The primary efficacy outcome was time to recurrent ischaemic stroke between treatment groups. The primary safety outcome was major bleeding, according to the criteria of the International Society of Thrombosis and Haemostasis. The primary analyses were based on the intention-to-treat population. Additionally, we did a systematic review and random-effects meta-analysis of studies in which patients with cryptogenic stroke and PFO were randomly assigned to receive anticoagulant or antiplatelet therapy. Findings: Between Dec 23, 2014, and Sept 20, 2017, 7213 participants were enrolled and assigned to receive rivaroxaban (n=3609) or aspirin (n=3604). Patients were followed up for a mean of 11 months because of early trial termination. PFO was reported as present in 534 (7·4%) patients on the basis of either TTE or TOE. Patients with PFO assigned to receive aspirin had a recurrent ischaemic stroke rate of 4·8 events per 100 person-years compared with 2·6 events per 100 person-years in those treated with rivaroxaban. Among patients with known PFO, there was insufficient evidence to support a difference in risk of recurrent ischaemic stroke between rivaroxaban and aspirin (hazard ratio [HR] 0·54; 95% CI 0·22–1·36), and the risk was similar for those without known PFO (1·06; 0·84–1·33; pinteraction=0·18). The risks of major bleeding with rivaroxaban versus aspirin were similar in patients with PFO detected (HR 2·05; 95% CI 0·51–8·18) and in those without PFO detected (HR 2·82; 95% CI 1·69–4·70; pinteraction=0·68). The random-effects meta-analysis combined data from NAVIGATE ESUS with data from two previous trials (PICSS and CLOSE) and yielded a summary odds ratio of 0·48 (95% CI 0·24–0·96; p=0·04) for ischaemic stroke in favour of anticoagulation, without evidence of heterogeneity. Interpretation: Among patients with ESUS who have PFO, anticoagulation might reduce the risk of recurrent stroke by about half, although substantial imprecision remains. Dedicated trials of anticoagulation versus antiplatelet therapy or PFO closure, or both, are warranted. Funding: Bayer and Janssen